NDVIX
Price
$18.06
Change
-$0.71 (-3.78%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

NDVIX vs VSIAX

Header iconNDVIX vs VSIAX Comparison
Open Charts NDVIX vs VSIAXBanner chart's image
MFS New Discovery Value I
Price$18.06
Change-$0.71 (-3.78%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
NDVIX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NDVIX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDVIX is a StrongSell and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. NDVIX (3.44B). VSIAX pays higher dividends than NDVIX: VSIAX (2.01) vs NDVIX (1.14). NDVIX was incepted earlier than VSIAX: NDVIX (14 years) vs VSIAX (13 years). NDVIX is a more actively managed with annual turnover of: 30.00 vs. VSIAX (16.00). NDVIX has a lower initial minimum investment than VSIAX: NDVIX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. NDVIX (9.25). VSIAX return over 5 years is better than : 52.83 vs. NDVIX (17.83).
NDVIXVSIAXNDVIX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years13 years-
Gain YTD7.89615.03153%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.44B63B5%
Annual Yield % from dividends1.142.0156%
Returns for 1 year9.2516.2357%
Returns for 3 years-1.6020.67-8%
Returns for 5 years17.8352.8334%
Returns for 10 years57.46105.6554%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics